Discover how a gingivectomy treats gum disease and improves aesthetics. Learn about the procedure, pain levels, and costs ...
As Amgen waits for an FDA decision on a second indication for its B cell-depleting therapy Uplizna, it has new data suggesting a third may be coming down the pipe. New data from the phase 3 MINT trial ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results